Name: 글로벌 시장 동향
SKU: MD7678
Availability: InStock

보고서 요약(국문)

개요
전 세계 안구 외상 기기 시장은 2022년 XX백만 달러에 도달했으며, 2023년부터 2030년까지 연평균 XX%의 성장률을 기록하며 2030년에는 XX백만 달러에 이를 것으로 예상됩니다.
안구 외상은 눈, 눈꺼풀 또는 눈 주위 뼈에 발생한 모든 손상을 의미합니다. 안구 외상은 경미한 손상부터 심각한 손상까지 다양하며, 시력 상실로 이어질 수도 있습니다. 눈 부상은 둔탁한 충격, 날카로운 물체 또는 화학적 충격에 의해 발생할 수 있습니다. 안구 외상 기기는 특히 눈 부상이나 외상의 진단, 치료 또는 관리를 위해 개발 및 사용됩니다.
시장 동향: 성장 동인 및 제약 요인
신제품 출시
눈 부상 사례의 증가가 예측 기간 동안 전 세계 안구 외상 기기 시장의 성장을 촉진할 것으로 예상됩니다. 예를 들어, 미국 국립보건원(NIH)에 따르면 눈 외상은 모든 신체 부상의 7%, 모든 안과 질환의 10~15%를 차지합니다. 전 세계적으로 눈 부상으로 인해 실명한 사람은 약 160만 명이며, 양쪽 눈 시력이 모두 저하된 사람은 230만 명 이상, 한쪽 눈 시력을 잃은 사람은 약 190만 명에 달합니다. 또한, 실명예방기구(Prevent Blindness Organization)에 따르면 미국에서도 약 100만 명이 눈 외상으로 인해 시력을 일부 상실했습니다. 매년 70만 명 이상의 미국인이 직장에서 눈 부상을 당합니다. 세계보건기구(WHO) 실명 데이터뱅크에 따르면 전 세계적으로 매년 약 5,500만 건의 눈 부상이 발생하며, 이로 인해 약 2,300만 명이 한쪽 눈 시력 저하를 겪고 약 75만 명이 입원 치료를 받습니다. 이러한 사례 증가, 투자 증가, 기술 발전은 예측 기간 동안 세계 시장 성장을 견인하는 추가적인 요인입니다.

엄격한 규제 당국
미국 식품의약국(FDA)과 유럽의약품청(EMA)과 같은 엄격한 규제 당국이 안구 외상 기기의 개발 및 상용화를 승인하는 것은 예측 기간 동안 세계 시장 성장을 저해하는 주요 요인 중 하나입니다. 또한, 높은 기기 가격, 제품 리콜, 숙련된 전문가 부족은 예측 기간 동안 세계 시장 성장을 둔화시킬 것으로 예상됩니다.
세분화 분석
세계 안구 외상 기기 시장은 기기 유형, 적응증, 최종 사용자 및 지역별로 세분화됩니다.
임플란트 유형: 안구 외상 기기 부문, 시장 주도 예상
임플란트 제품 승인 증가로 인해 이 부문은 예측 기간 동안 세계 시장을 주도할 것으로 예상됩니다. 예를 들어, 진단 및 제약 개발 기업인 로슈(Roche)는 2021년 10월 미국 식품의약국(FDA)으로부터 시력 저하를 유발하는 만성 질환 치료용 안구 임플란트 승인을 받았습니다. 또한, 2023년 3월에는 픽시움 비전(Pixium Vision)이 위축성 건성 황반변성 환자의 시력을 부분적으로 교정하기 위해 개발된 임플란트인 프리마 시스템(Prima System)에 대해 FDA 혁신 의료기기 지정을 받았습니다.

지리적 분석
북미 지역이 세계 시장을 주도할 것으로 예상됩니다.
북미 지역의 시장 개발이 활발히 진행되고 안구 외상 사례가 증가함에 따라, 향후 예측 기간 동안 북미 지역이 세계 시장을 주도할 것으로 전망됩니다. 예를 들어, 2022년 6월, 제약 회사인 EyePoint Pharmaceuticals, Inc.의 자회사 pSivida는 안구 염증 치료용 임플란트에 대해 중국 규제 당국의 승인을 획득하여, 실제 임상 데이터만을 기반으로 중국에서 승인을 받은 최초의 기업이 되었습니다. 또한, 미국 안과학회에 따르면 매년 미국에서 약 240만 건의 안구 손상이 발생하고 있습니다. 미국 노동통계국에 따르면 매년 약 2만 건의 산업재해성 안구 손상이 발생하며, 매일 약 2,000명의 미국 근로자가 업무 관련 안구 손상으로 치료를 받고 있습니다.

코로나19 영향 분석
코로나19 팬데믹은 시장에 부정적인 영향을 미쳤습니다. 병원에서는 1차 또는 2차 의료기관의 긴급 의뢰 환자, 외래 응급 환자, 그리고 입원 치료가 필요한 환자만 진료했기 때문입니다. 선택적 안과 시술과 외래 진료는 봉쇄 조치로 인해 연기되었습니다. 이러한 상황은 팬데믹 기간 동안 시장에 영향을 미쳤지만, 팬데믹 이후 매출 증가로 손실이 상쇄될 것으로 예상됩니다.

시장 세분화
기기 유형별
• 임플란트
• 기구
• 일회용품
적응증별
• 둔상
• 화학적 외상
• 예리한 물체에 의한 외상
최종 사용자별
• 병원
• 전문 클리닉
• 기타
지역별
• 북미
o 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 이탈리아
o 스페인
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양
o 중국
o 인도
o 일본
o 호주
o 기타 아시아 태평양
• 중동 및 아프리카
주요 개발 동향
• 2023년 3월, 안구 외상 회복 속도를 높이는 제품을 개발한 노팅엄 소재 기업 NuVision이 110만 파운드의 추가 투자를 유치했습니다.

• 2022년 4월, CorneaGen은 EndoSerter-PL을 출시했습니다. 이 새로운 FDA 승인 일회용 이식 삽입 장치는 DSEK 수술 과정을 간소화하기 위해 전문적으로 처리된 조직이 미리 장착되어 있습니다.
• 2022년 1월, 안과 제품 전문 미국-스위스 의료기기 회사인 알콘(Alcon)은 녹내장 수술 기기인 하이드러스 마이크로스텐트(Hydrus Microstent)를 개발한 이반티스(Ivantis)를 인수했습니다.
경쟁 환경
주요 글로벌 시장 참여 업체로는 바슈앤롬(Bausch & Lomb, Inc.), 칼 자이스(Carl Zeiss AG), 알콘(Alcon), 존슨앤존슨 비전(Johnson & Johnson Vision), 쿠퍼비전(CooperVision), 에실로룩소티카(EssilorLuxottica), 호야(Hoya Corporation), 글라우코스(Glaukos Corporation), 아이리덱스(IRIDEX Corporation), 라이카 마이크로시스템즈(Leica Microsystems GmbH) 등이 있습니다.
보고서 구매 이유

• 기기 유형, 적응증, 최종 사용자 및 지역별 글로벌 안구 외상 기기 시장 세분화를 시각화하고 주요 상업 자산 및 업체를 파악하기 위함입니다.

• 트렌드 및 공동 개발 분석을 통해 사업 기회를 식별하기 위함입니다.

• 모든 세그먼트를 포함한 안구 외상 기기 시장 수준의 다양한 데이터가 담긴 엑셀 데이터 시트를 제공합니다.

• PDF 보고서는 철저한 질적 인터뷰와 심층 연구를 바탕으로 한 종합적인 분석 자료로 구성됩니다.

• 주요 업체들의 핵심 제품을 모두 포함하는 제품 맵핑 자료는 엑셀 파일로 제공됩니다.
글로벌 안구 외상 기기 시장 보고서는 약 61개의 표, 57개의 그림, 184페이지 분량입니다.
주요 독자층 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global Ocular Trauma Devices market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030, growing at a CAGR of XX% during the forecast period 2023-2030.
Ocular trauma is any damage to the eye, eyelid, or covering bone around the eye. Ocular trauma can be nominal or extreme, even resulting in loss of eyesight. Injury to the eye is induced by blunt, sharp, or chemical trauma. Ocular trauma devices are particularly developed and utilized for the diagnosis, treatment, or management of eye injuries or traumas.
Market Dynamics: Drivers & Restraints
Product Launches
The growing cases of eye injuries are expected to boost the global ocular trauma devices market growth during the forecast period. For instance, according to NIH, eye trauma comprises 7% of all physical injuries and 10%–15% of all eye conditions. Globally, there are roughly 1.6 million individuals who are blind because of eye injuries, over 2.3 million are bilaterally visually challenged, and around 1.9 million retain unilateral visual loss. Moreover, according to the Prevent Blindness Organization, almost one million Americans have lost some extent of their sight owing to eye trauma. Over 700,000 Americans injure their eyes at work per year. Also, the World Health Organization's (WHO) Blindness Data Bank notes that roughly 55 million eye injuries happen worldwide yearly resulting in almost 23 million people with at least unilaterally poor vision and around 750,000 hospitalizations. These increasing cases, rising investments, and advances in technology are among the additional factors driving the global market growth during the forecast period.
Stringent Regulatory Authorities
The presence of stringent regulatory authorities like the FDA and EMA authorizing the development and commercialization of ocular trauma devices is among the major factors hampering the global market during the forecast period. Furthermore, the high device cost, product recalls and the lack of skilled professionals is also expected to slow the global market growth during the forecast period.
Segment Analysis
The global ocular trauma devices market is segmented based on device type, indication, end user and region.
Implants Type Ocular Trauma Devices Segment is Expected to Dominate Market
Owing to the increasing implant product approvals the segment is expected to dominate the global market during the forecast period. For instance, Roche, a healthcare corporation presenting diagnostic and pharmaceutical developments, obtained the Food and Drug Association in the U.S. authorization for its ocular implants to treat chronic diseases causing blurred vision in October 2021. Moreover, in March 2023, Pixium Vision was awarded the FDA breakthrough device designation to the Prima System, an implant developed to partly correct vision in individuals with atrophic dry age-related macular degeneration.
Geographical Analysis
North America is Expected to Dominate the Global Market
Owing to the increasing market developments and growing cases of ocular trauma in North America the region is expected to dominate the global market during the forecast period. For instance, in June 2022, EyePoint Pharmaceuticals, Inc., pSivida, a pharmaceutical corporation, obtained Chinese regulatory body clearance for an implant to treat a condition of eye inflammation, becoming the foremost corporation to obtain approval in the country founded completely on real-world data. Moreover, according to the American Academy of Ophthalmology, every year an estimated 2.4 million eye injuries occur in the United States. Also, according to the U.S. Bureau of Labor Statistics, approximately 20,000 eye injuries happen in the workplace every year and every day roughly 2,000 U.S. workers support a job-related eye injury that needs medical therapy.
COVID-19 Impact Analysis
The COVID-19 pandemic had a negative impact on the market, as only urgent referrals from primary or secondary health institutions, outpatient emergencies, and inpatients whose medical problems needed keeping them hospitalized were handled by hospitals. Elective eye procedures and clinics were postponed due to the imposed lockdowns. Although this affected the market during the pandemic, the loss is expected to be offset by an increase in sales post pandemic period.
Market Segmentation
By Device Type
• Implants
• Instruments
• Disposables
By Indication
• Blunt Trauma
• Chemical Trauma
• Sharp Trauma
By End User
• Hospitals
• Specialty Clinics
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Key Developments
• In March 2023, NuVision, a Nottingham-based corporation with a product that quickens up the recovery of eye trauma raised an additional £1.1m investment.
• In April 2022, CorneaGen, introduced the EndoSerter-PL. This new and only FDA-approved, single-use graft insertion device is pre-loaded with expertly processed tissue to help streamline DSEK surgeries.
• In January 2022, Alcon, an American Swiss medical device corporation that specializes in eye care products, acquired Ivantis, a firm that presented a glaucoma surgery device, the Hydrus Microstent.
Competitive Landscape
The major global players in the market include Bausch & Lomb, Inc., Carl Zeiss AG, Alcon, Johnson & Johnson Vision, CooperVision, EssilorLuxottica, Hoya Corporation, Glaukos Corporation, IRIDEX Corporation and Leica Microsystems GmbH
Why Purchase the Report?
• To visualize the global ocular trauma devices market segmentation based on device type, indication, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of ocular trauma devices market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key product of all the major players.
The global ocular trauma devices market report would provide approximately 61 tables, 57 figures and 184 pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Device Type
3.2. Snippet by Indication
3.3. Snippet by End User
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Product Launches
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1. Stringent Regulatory Authorities
4.1.2.2. XX
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Pricing Analysis
5.3. Regulatory Analysis
5.4. Patent Analysis
5.5. Unmet Need
5.6. SWOT Analysis
5.7. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Device Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
7.1.2. Market Attractiveness Index, By Device Type
7.2. Implants*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Instruments
7.4. Disposables
8. By Indication
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
8.1.2. Market Attractiveness Index, By Indication
8.2. Blunt Trauma*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Chemical Trauma
8.4. Sharp Trauma
9. By End User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Specialty Clinics
9.4. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. UK
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Bausch & Lomb, Inc.*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Carl Zeiss AG
12.3. Alcon, Inc.
12.4. JOHNSON & JOHNSON VISION
12.5. CooperVision
12.6. EssilorLuxottica
12.7. Hoya Corporation
12.8. Glaukos Corporation
12.9. IRIDEX Corporation
12.10. SOWECARE B.V
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us

언급된 주요 기업들

Bausch & Lomb, Inc., 4.	Key Developments, Carl Zeiss AG, Alcon, Inc., JOHNSON & JOHNSON VISION, CooperVision, EssilorLuxottica, Hoya Corporation, Glaukos Corporation, IRIDEX Corporation, SOWECARE B.V

표 목록 (Tables)

List of Tables

Table 1 Global Ocular Trauma Devices Market Value, By Device Type, 2022, 2026 & 2030 (US$ Million)

Table 2 Global Ocular Trauma Devices Market Value, By Indication, 2022, 2026 & 2030 (US$ Million)

Table 3 Global Ocular Trauma Devices Market Value, By End User, 2022, 2026 & 2030 (US$ Million)

Table 4 Global Ocular Trauma Devices Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 5 Global Ocular Trauma Devices Market Value, By Device Type, 2022, 2026 & 2030 (US$ Million)

Table 6 Global Ocular Trauma Devices Market Value, By Device Type, 2021-2030 (US$ Million)

Table 7 Global Ocular Trauma Devices Market Value, By Indication, 2022, 2026 & 2030 (US$ Million)

Table 8 Global Ocular Trauma Devices Market Value, By Indication, 2021-2030 (US$ Million)

Table 9 Global Ocular Trauma Devices Market Value, By End User, 2022, 2026 & 2030 (US$ Million)

Table 10 Global Ocular Trauma Devices Market Value, By End User, 2021-2030 (US$ Million)

Table 11 Global Ocular Trauma Devices Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 12 Global Ocular Trauma Devices Market Value, By Region, 2021-2030 (US$ Million)

Table 13 North America Ocular Trauma Devices Market Value, By Device Type, 2021-2030 (US$ Million)

Table 14 North America Ocular Trauma Devices Market Value, By Indication, 2021-2030 (US$ Million)

Table 15 North America Ocular Trauma Devices Market Value, By End User, 2021-2030 (US$ Million)

Table 16 North America Ocular Trauma Devices Market Value, By Country, 2021-2030 (US$ Million)

Table 17 South America Ocular Trauma Devices Market Value, By Device Type, 2021-2030 (US$ Million)

Table 18 South America Ocular Trauma Devices Market Value, By Indication, 2021-2030 (US$ Million)

Table 19 South America Ocular Trauma Devices Market Value, By End User, 2021-2030 (US$ Million)

Table 20 South America Ocular Trauma Devices Market Value, By Country, 2021-2030 (US$ Million)

Table 21 Europe Ocular Trauma Devices Market Value, By Device Type, 2021-2030 (US$ Million)

Table 22 Europe Ocular Trauma Devices Market Value, By Indication, 2021-2030 (US$ Million)

Table 23 Europe Ocular Trauma Devices Market Value, By End User, 2021-2030 (US$ Million)

Table 24 Europe Ocular Trauma Devices Market Value, By Country, 2021-2030 (US$ Million)

Table 25 Asia-Pacific Ocular Trauma Devices Market Value, By Device Type, 2021-2030 (US$ Million)

Table 26 Asia-Pacific Ocular Trauma Devices Market Value, By Indication, 2021-2030 (US$ Million)

Table 27 Asia-Pacific Ocular Trauma Devices Market Value, By End User, 2021-2030 (US$ Million)

Table 28 Asia-Pacific Ocular Trauma Devices Market Value, By Country, 2021-2030 (US$ Million)

Table 29 Middle East & Africa Ocular Trauma Devices Market Value, By Device Type, 2021-2030 (US$ Million)

Table 30 Middle East & Africa Ocular Trauma Devices Market Value, By Indication, 2021-2030 (US$ Million)

Table 31 Middle East & Africa Ocular Trauma Devices Market Value, By End User, 2021-2030 (US$ Million)

Table 32 Bausch & Lomb, Inc.: Overview

Table 33 Bausch & Lomb, Inc.: Product Portfolio

Table 34 Bausch & Lomb, Inc.: Key Developments

Table 35 Carl Zeiss AG: Overview

Table 36 Carl Zeiss AG: Product Portfolio

Table 37 Carl Zeiss AG: Key Developments

Table 38 Alcon, Inc.: Overview

Table 39 Alcon, Inc.: Product Portfolio

Table 40 Alcon, Inc.: Key Developments

Table 41 JOHNSON & JOHNSON VISION: Overview

Table 42 JOHNSON & JOHNSON VISION: Product Portfolio

Table 43 JOHNSON & JOHNSON VISION: Key Developments

Table 44 CooperVision: Overview

Table 45 CooperVision: Product Portfolio

Table 46 CooperVision: Key Developments

Table 47 EssilorLuxottica: Overview

Table 48 EssilorLuxottica: Product Portfolio

Table 49 EssilorLuxottica: Key Developments

Table 50 Hoya Corporation: Overview

Table 51 Hoya Corporation: Product Portfolio

Table 52 Hoya Corporation: Key Developments

Table 53 Glaukos Corporation: Overview

Table 54 Glaukos Corporation: Product Portfolio

Table 55 Glaukos Corporation: Key Developments

Table 56 IRIDEX Corporation: Overview

Table 57 IRIDEX Corporation: Product Portfolio

Table 58 IRIDEX Corporation: Key Developments

Table 59 SOWECARE B.V: Overview

Table 60 SOWECARE B.V: Product Portfolio

Table 61 SOWECARE B.V: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Ocular Trauma Devices Market Value, 2021-2030 (US$ Million)

Figure 2 Global Ocular Trauma Devices Market Share, By Device Type, 2022 & 2030 (%)

Figure 3 Global Ocular Trauma Devices Market Share, By Indication, 2022 & 2030 (%)

Figure 4 Global Ocular Trauma Devices Market Share, By End User, 2022 & 2030 (%)

Figure 5 Global Ocular Trauma Devices Market Share, By Region, 2022 & 2030 (%)

Figure 6 Global Ocular Trauma Devices Market Y-o-Y Growth, By Device Type, 2022-2030 (%)

Figure 7 Implants Ocular Trauma Devices Market Value, 2021-2030 (US$ Million)

Figure 8 Instruments Ocular Trauma Devices Market Value, 2021-2030 (US$ Million)

Figure 9 Disposables Ocular Trauma Devices Market Value, 2021-2030 (US$ Million)

Figure 10 Global Ocular Trauma Devices Market Y-o-Y Growth, By Indication, 2022-2030 (%)

Figure 11 Blunt Trauma Indication in Global Ocular Trauma Devices Market Value, 2021-2030 (US$ Million)

Figure 12 Chemical Trauma Indication in Global Ocular Trauma Devices Market Value, 2021-2030 (US$ Million)

Figure 13 Sharp Trauma Indication in Global Ocular Trauma Devices Market Value, 2021-2030 (US$ Million)

Figure 14 Global Ocular Trauma Devices Market Y-o-Y Growth, By End User, 2022-2030 (%)

Figure 15 Hospitals End User in Global Ocular Trauma Devices Market Value, 2021-2030 (US$ Million)

Figure 16 Specialty Clinics End User in Global Ocular Trauma Devices Market Value, 2021-2030 (US$ Million)

Figure 17 Others End User in Global Ocular Trauma Devices Market Value, 2021-2030 (US$ Million)

Figure 18 Global Ocular Trauma Devices Market Y-o-Y Growth, By Region, 2022-2030 (%)

Figure 19 North America Ocular Trauma Devices Market Value, 2021-2030 (US$ Million)

Figure 20 Asia-Pacific Ocular Trauma Devices Market Value, 2021-2030 (US$ Million)

Figure 21 Europe Ocular Trauma Devices Market Value, 2021-2030 (US$ Million)

Figure 22 South America Ocular Trauma Devices Market Value, 2021-2030 (US$ Million)

Figure 23 Middle East and Africa Ocular Trauma Devices Market Value, 2021-2030 (US$ Million)

Figure 24 North America Ocular Trauma Devices Market Value, 2021-2030 (US$ Million)

Figure 25 North America Ocular Trauma Devices Market Share, By Device Type, 2022 & 2030 (%)

Figure 26 North America Ocular Trauma Devices Market Share, By Indication, 2022 & 2030 (%)

Figure 27 North America Ocular Trauma Devices Market Share, By End User, 2022 & 2030 (%)

Figure 28 North America Ocular Trauma Devices Market Share, By Country, 2022 & 2030 (%)

Figure 29 South America Ocular Trauma Devices Market Value, 2021-2030 (US$ Million)

Figure 30 South America Ocular Trauma Devices Market Share, By Device Type, 2022 & 2030 (%)

Figure 31 South America Ocular Trauma Devices Market Share, By Indication, 2022 & 2030 (%)

Figure 32 South America Ocular Trauma Devices Market Share, By End User, 2022 & 2030 (%)

Figure 33 South America Ocular Trauma Devices Market Share, By Country, 2022 & 2030 (%)

Figure 34 Europe Ocular Trauma Devices Market Value, 2021-2030 (US$ Million)

Figure 35 Europe Ocular Trauma Devices Market Share, By Device Type, 2022 & 2030 (%)

Figure 36 Europe Ocular Trauma Devices Market Share, By Indication, 2022 & 2030 (%)

Figure 37 Europe Ocular Trauma Devices Market Share, By End User, 2022 & 2030 (%)

Figure 38 Europe Ocular Trauma Devices Market Share, By Country, 2022 & 2030 (%)

Figure 39 Asia-Pacific Ocular Trauma Devices Market Value, 2021-2030 (US$ Million)

Figure 40 Asia-Pacific Ocular Trauma Devices Market Share, By Device Type, 2022 & 2030 (%)

Figure 41 Asia-Pacific Ocular Trauma Devices Market Share, By Indication, 2022 & 2030 (%)

Figure 42 Asia-Pacific Ocular Trauma Devices Market Share, By End User, 2022 & 2030 (%)

Figure 43 Asia-Pacific Ocular Trauma Devices Market Share, By Country, 2022 & 2030 (%)

Figure 44 Middle East & Africa Ocular Trauma Devices Market Value, 2021-2030 (US$ Million)

Figure 45 Middle East & Africa Ocular Trauma Devices Market Share, By Device Type, 2022 & 2030 (%)

Figure 46 Middle East & Africa Ocular Trauma Devices Market Share, By Indication, 2022 & 2030 (%)

Figure 47 Middle East & Africa Ocular Trauma Devices Market Share, By End User, 2022 & 2030 (%)

Figure 48 Bausch & Lomb, Inc.: Financials

Figure 49 Carl Zeiss AG: Financials

Figure 50 Alcon, Inc.: Financials

Figure 51 JOHNSON & JOHNSON VISION: Financials

Figure 52 CooperVision: Financials

Figure 53 EssilorLuxottica: Financials

Figure 54 Hoya Corporation: Financials

Figure 55 Glaukos Corporation: Financials

Figure 56 IRIDEX Corporation: Financials

Figure 57 SOWECARE B.V: Financials

글로벌 안구 외상 의료기기 시장 – 2023-2030

Global Ocular Trauma Devices Market - 2023-2030